Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 2017 ESC guidelines focus on dual antiplatelet therapy.

Literature DB >> 30052849

2017 ESC guidelines focus on dual antiplatelet therapy.

Giuseppe M C Rosano^1,2, Petar Seferovic³.

Abstract

Mesh：

Substances：

Year: 2018 PMID： 30052849 DOI： 10.1093/ehjcvp/pvy007

Source DB: PubMed Journal: Eur Heart J Cardiovasc Pharmacother

Keyword Cloud
Cited

× No keyword cloud information.

3 in total

1. The AKR1D136* (rs1872930) Allelic Variant Is Independently Associated With Clopidogrel Treatment Outcome.

Authors: Aleksandra Kapedanovska-Nestorovska; Aleksandar J Dimovski; Zoran Sterjev; Nadica Matevska Geskovska; Ljubica Suturkova; Petar Ugurov; Zan Mitrev; Rodney Rosalia
Journal: Pharmgenomics Pers Med Date: 2019-10-21

2. Who approves/pays for additional monitoring?

Authors: Giuseppe M C Rosano; Ilaria Spoletini; Cristiana Vitale
Journal: Eur Heart J Suppl Date: 2019-12-31 Impact factor: 1.803

3. Real-World Bleeding and Ischemic Events in Asian Patients on P2Y12-Inhibitors After Percutaneous Coronary Intervention: A National Claims Data Analysis.

Authors: Yonggu Lee; Young-Hyo Lim; Yongwhi Park; Jinho Shin
Journal: Adv Ther Date: 2020-11-11 Impact factor: 3.845

3 in total

2017 ESC guidelines focus on dual antiplatelet therapy.

1. The AKR1D1*36 (rs1872930) Allelic Variant Is Independently Associated With Clopidogrel Treatment Outcome.

2. Who approves/pays for additional monitoring?

3. Real-World Bleeding and Ischemic Events in Asian Patients on P2Y12-Inhibitors After Percutaneous Coronary Intervention: A National Claims Data Analysis.

1. The AKR1D136* (rs1872930) Allelic Variant Is Independently Associated With Clopidogrel Treatment Outcome.